Bloomberg Markets
Parabilis Medicines Inc. shares jumped as much as 67% in its trading debut, after the company raised nearly $745 million in an upsized US initial public offering that priced above its marketed range and a private placement.
Go to News Site
MarketWatch
CNBC
Quartz
Black Enterprise
Quartz
CNBC
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets
Bloomberg Markets